In lung carcinomas, ALK rearrangement was first demonstrated in 2007 by Soda et al. (33) when ALK fusion transcripts were found in 6.7% (5 out of 75) of NSCLC samples. This evidence concerns the gene ALK and non-small cell lung carcinoma.